PR Newswire
NEW BRUNSWICK, N.J., Aug. 29, 2019
NEW BRUNSWICK, N.J., Aug. 29, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, at The Grand Hyatt Hotel in New York. Peter F. Lebowitz, M.D., Ph.D. Global Therapeutic Area Head, Oncology and Scott White, Company Group Chairman North America Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately two hours after the live webcast.
View original content to download multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-2019-morgan-stanley-17th-annual-global-healthcare-conference-300909436.html
SOURCE Johnson & Johnson
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member